コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 birth defects, ranging from microcephaly to hearing impairment.
2 ty of a link between K(v)1.1 dysfunction and hearing impairment.
3 normal hearing listeners and other forms of hearing impairment.
4 within 19 genetic intervals associated with hearing impairment.
5 or a substantial proportion of patients with hearing impairment.
6 vere thyroid hormone deficiency and profound hearing impairment.
7 d can be a significant burden for those with hearing impairment.
8 135G>T [p.Glu379X]) in ILDR1 as the cause of hearing impairment.
9 rlying nonsyndromic prelingual sensorineural hearing impairment.
10 of the mechanisms of hypothyroidism-induced hearing impairment.
11 th an increased risk of substantial neonatal hearing impairment.
12 ner ear histology suggestive of a conductive hearing impairment.
13 e unit (NICU), and one of them had bilateral hearing impairment.
14 thyroid hormone dysregulation in age-related hearing impairment.
15 vating neurons is the most frequent cause of hearing impairment.
16 d neural system of the inner ear, leading to hearing impairment.
17 nd travel, among individuals who also have a hearing impairment.
18 ing a person's susceptibility to age-related hearing impairment.
19 s in cochlear hair cells, and thus relate to hearing impairment.
20 t heterozygous mice do not suffer peripheral hearing impairment.
21 d with a higher likelihood of developing any hearing impairment.
22 w of the genetic architecture of age-related hearing impairment.
23 molecular mechanisms underlying hearing and hearing impairment.
24 autosomal dominant, nonsyndromic hereditary hearing impairment.
25 universal neonatal screening programmes for hearing impairment.
26 egated with the inherited autosomal dominant hearing impairment.
27 a conditioning tone, perhaps attributable to hearing impairment.
28 characterized by congenital mild-to-moderate hearing impairment.
29 at least 30 autosomal loci for nonsyndromic hearing impairment.
30 vement in immobility, visual impairment, and hearing impairment.
31 sclerosis is the single most common cause of hearing impairment.
32 ry disorder that causes hypopigmentation and hearing impairment.
33 characterized by congenital mild-to-moderate hearing impairment.
34 0 of these children have moderate or greater hearing impairment.
35 111 out of 287 participants had hearing impairment.
36 brillation, cancer, asthma, and deafness and hearing impairment.
37 ccine compared with adults with little to no hearing impairment.
38 hearing impairment, and 121 (4%) had severe hearing impairment.
39 1 in 4 people worldwide will be living with hearing impairment.
40 ccine compared with adults with little to no hearing impairment.
41 ese myosins in patients suffering visual and hearing impairment.
42 normal hearing or mild, moderate, or severe hearing impairment.
43 hypertonia, visual problems, and conductive hearing impairment.
44 egenerate after damage, leading to permanent hearing impairment.
45 pumps, OHCs degenerate, leading to profound hearing impairment.
46 uced myelination might augment sensorineural hearing impairment.
47 idneys, diabetes, hepatitis, depression, and hearing impairment.
48 sleep deprivation, immobility and visual and hearing impairment.
49 l hearing and 7 with bilateral sensorineural hearing impairment.
50 deficit, cerebral palsy, or severe visual or hearing impairment.
51 RP) with or without congenital sensorineural hearing impairment.
52 CNS mechanisms are affected by a peripheral hearing impairment.
53 icity in the perceptual sequelae of cochlear hearing impairment.
54 gic disease, brain lesions, drug effect, and hearing impairment.
55 ptors of the auditory system re-emerges with hearing impairment.
56 ign of damage in both noise- and age-related hearing impairment.
57 oaches and medical care for LF patients with hearing impairment.
58 r, and prognostic indicator, for age-related hearing impairment.
59 , indicating hair cell dysfunction and gross hearing impairment.
60 in a socially excluded group of people with hearing impairment.
61 examined a clinical cohort of subjects with hearing impairment.
62 tation had symmetric, mild-to-moderate mixed hearing impairment.
63 isk for psychosis is observed in people with hearing impairment.
64 r diagnosis of cerebral palsy and visual and hearing impairments.
65 studies in older humans when controlling for hearing impairments.
66 s that cause severe prelingual non-syndromic hearing impairments.
67 e fibers, can lead to profound and permanent hearing impairments.
68 ls to the auditory nerve leads to undetected hearing impairments.
69 cues, posing challenges for individuals with hearing impairments.
70 00), IGF-1 was associated with lower odds of hearing impairment (0.86; 0.73, 1.00) after adjustment f
72 missense variants in PLCG1 who present with hearing impairment (5/7), ocular pathology (4/7), cardia
73 ants had normal hearing, 1170 (40%) had mild hearing impairment, 692 (23%) had moderate hearing impai
75 he appropriate compensation of sensorineural hearing impairment across a range of frequencies (e.g.,
76 ous for KARS mutations had symmetric, severe hearing impairment across all frequencies but did not sh
77 family with autosomal dominant nonsyndromic hearing impairment (ADNSHI) was enrolled in this study.
80 [aHR], 1.89; 95% CI, 1.57-2.28), functional hearing impairment (aHR, 1.14; 95% CI, 1.00-1.31), and f
81 ter than the effects of vision impairment or hearing impairment alone, because when these two sensory
83 protective effects on hypothyroidism-induced hearing impairment, an F1 intercross was generated betwe
84 improvement indices of 0.21 (P = 0.008) for hearing impairment and 0.26 (P < 0.001) for mobility imp
85 n leads to the DFNA17 phenotype (progressive hearing impairment and cochleosaccular degeneration) rem
86 ) did not attenuate the associations between hearing impairment and cognition (global cognition: unst
88 recent intense interest in the link between hearing impairment and dementia, comprehension of acoust
89 uated and considered in future management of hearing impairment and design of auditory prostheses.
92 ion are advancing molecular understanding of hearing impairment and the complex mechanisms of the aud
93 screening for permanent bilateral childhood hearing impairment and the effects of confirmation of he
96 mammalian vertebrates can fully recover from hearing impairments and balance dysfunctions because sup
98 search tool that can elucidate the nature of hearing impairments and suggest or eliminate compensator
99 d hearing impairment, 692 (23%) had moderate hearing impairment, and 121 (4%) had severe hearing impa
105 children aged 6-19 years have some degree of hearing impairment, and over 216,000 of these children h
107 iovascular disease, itself a risk factor for hearing impairment, and, in animal studies, molecular ev
108 OC, innervation, which likely contributes to hearing impairments, and a relative paucity of MOC termi
109 a range of adverse listening conditions and hearing impairments, and even for users of cochlear impl
110 , cognitive impairments, vision impairments, hearing impairments, and motor impairments) using compre
112 sms by which cardiovascular disease risk and hearing impairment are collectively associated with cogn
118 damage to the inner ear is a major cause of hearing impairment, arising from exposures occurring dur
119 within the autosomal-recessive nonsyndromic hearing impairment (ARNSHI) locus DFNB68 on 19p13.2.
120 ciated with autosomal-recessive nonsyndromic hearing impairment (ARNSHI), was mapped to chromosomal r
121 ate the ability of the dSHS to help rule out hearing impairment as a cause or confounder in clinical
122 ever, Mcu(-/-) mice displayed high-frequency hearing impairment as early as 3 weeks postnatal, which
123 bjects (8%) and 0 of 13 control subjects had hearing impairment, as did 1 nonrandomized subject.
124 e to the aetiology of amblyaudia, a binaural hearing impairment associated with bouts of otitis media
126 formation of the heart and other organs, and hearing impairment associated with recurrent ear infecti
130 ng loss gene, has been linked to age-related hearing impairment before, and in addition is preferenti
131 mpairment and the effects of confirmation of hearing impairment by nine months of age on subsequent v
134 family members in three generations: 10 with hearing impairment caused by the DFNA23 locus, 8 unaffec
136 ogical abnormalities of the external ear and hearing impairment (conductive or sensorineural) affect
137 fects, but three of 11 surviving infants had hearing impairment confirmed on auditory testing between
138 la syndrome include cataracts, sensorineural hearing impairment, congenital heart disease, jaundice,
139 as immobility, functional decline, visual or hearing impairment, dehydration, and sleep deprivation a
140 or mobility impairment), sensory (visual or hearing impairments), developmental (intellectual or dev
142 have been linked to non-syndromic hereditary hearing impairment DFNA17 as well as 'MYH9-related disea
143 me type IB, autosomal-recessive nonsyndromic hearing impairment (DFNB2), and autosomal-dominant nonsy
145 ice, in contrast, present with non-syndromic hearing impairment due to the effects of multiple genes
149 nt such that hyperglycemia in the context of hearing impairment exacerbated poor performance on learn
150 holistic approaches to health management and hearing impairment, (f) universal access to evolving and
152 iption cofactor Eyes absent 4 (Eya4), causes hearing impairment followed by dilative cardiomyopathy.
153 a reduced likelihood of functional recovery: hearing impairment, greater increase in postsurgical dis
154 associated with functional recovery, whereas hearing impairment, greater increases in postsurgical di
155 categorized into normal (BPTA <=25 dB), mild hearing impairment (>25 to 40 dB), and moderate or great
157 US population, and prevalences of vision and hearing impairment have been extensively evaluated.
162 #267300) often associated with sensorineural hearing impairment; however, mice with a knockout mutati
163 ry, smoking, body mass index, and vision and hearing impairment (HR = 1.05, 95% CI = 1.03-1.07, p < 0
164 tudied 120 children with bilateral permanent hearing impairment identified from a large birth cohort
165 reduced hearing ability and the duration of hearing impairment in 42 unilateral hearing loss (UHL) p
166 0 on screening for age-related sensorineural hearing impairment in adults aged 50 years or older with
169 The condition began with high-frequency hearing impairment in all family members excluding III:2
170 effect of birth cohort on the prevalence of hearing impairment in an adult population aged 45-94 yea
171 as performed for 273 participants and showed hearing impairment in at least 1 ear, most commonly mild
172 tations in the POU domain gene Brn-3c causes hearing impairment in both the human and mouse as a resu
177 iants co-segregates with congenital profound hearing impairment in consanguineous Pakistani families
181 icate that the short nose, otitis media, and hearing impairment in Jacobsen syndrome are likely becau
186 1 appeared to confer some protection against hearing impairment in some older adults warrants replica
189 o national guidelines, and the prevalence of hearing impairment in the two groups was compared by usi
191 amily with X-linked postlingual nonsyndromic hearing impairment in which the critical linkage interva
192 the genetic and physiological bases of human hearing impairment, including both early- and late-onset
193 a range of adverse listening conditions and hearing impairments, including cochlear implant-supporte
194 , TR beta 2-null mice exhibit no evidence of hearing impairment, indicating that TR beta 1 and TR bet
196 Given that the frequency of all childhood hearing impairment is 1/1,000 and that half of that is g
201 vous system symptoms, visual disturbance and hearing impairment is an oft-encountered clinical scenar
207 genetic deafness is non-syndromic, in which hearing impairment is not associated with any other abno
210 mporal resolution in listeners with cochlear hearing impairment is presented with the aim of assessin
211 autosomal dominant late-onset non-syndromic hearing impairment is segregating, we have identified a
217 the link between IGF-1 and the occurrence of hearing impairment is untested in population-based studi
218 ied mutation in CABP2 that causes a moderate hearing impairment likely via nonsense-mediated decay of
219 y, a novel autosomal recessive non-syndromic hearing impairment locus DFNB44 was mapped to chromosome
222 generation and a moderate but nonprogressive hearing impairment, mimicking the visual and hearing def
223 hich were not included in prior risk models: hearing impairment, mobility impairment, weight loss, an
224 for blindness (0.9% vs 0%; P = .02), and for hearing impairment (moderate and severe, 0.9% vs 0%; P =
225 d when exposed to asymmetrical mild-moderate hearing impairment, more specifically on the ipsilateral
226 sifiable category where 67.2% had documented hearing impairment, more than in any other group (P < 0.
227 benefit to individuals in all categories of hearing impairment (normal, mild, moderate, severe, and
230 ho had confirmed bilateral OME and bilateral hearing impairment of 25-70 dB of at least 3 months' dur
233 y, age-adjusted prevalence of high-frequency hearing impairment of mild or greater severity in the wo
234 adjusted prevalence of low- or mid-frequency hearing impairment of mild or greater severity in the wo
236 uditory hair cell defect is a major cause of hearing impairment, often leading to spiral ganglia neur
237 is of clinically diagnosed and self-reported hearing impairment on 723,266 individuals and identified
238 uditory brainstem responses indicated a mild hearing impairment on hair cell-specific deletion of all
241 85); deafness (OR, 2.19; 95% CI, 1.17-4.12); hearing impairment (OR,1.55; 95% CI, 1.29-1.87); upper e
242 tory factors such as neurological disorders, hearing impairment, or lack of adequate opportunity-are
244 rt, IGF-1 was not associated with subsequent hearing impairment (OR5nmol/L increase; 95% CI: 1.01; 0.
245 ive protein levels, lower handgrip strength, hearing impairment, orthostatic hypotension, stroke, dia
247 , personal or parental history of migration, hearing impairment, parental age, parental income, paren
248 ement for infants with a permanent childhood hearing impairment (PCHI) during 2011-2015 at a U.K. ser
249 born screening (UNS) for permanent childhood hearing impairment (PCHI) was undertaken to establish wh
250 Group [ECOG] performance status 2, renal or hearing impairment, peripheral neuropathy, aged at least
251 riants both segregated with the nonsyndromic-hearing-impairment phenotype within the three families,
252 ost common sensory disorder, with congenital hearing impairment present in approximately 1 in 1,000 n
255 e brain revealed a significant enrichment of hearing impairment-related oligos in the SOC (26 in the
256 ents surviving BTs were at elevated risk for hearing impairments (relative risk [RR], 17.3; P = <.000
257 ad an increased risk of exacerbations but no hearing impairment, resting tachycardia, or apparent ris
261 ver, cardiovascular grouping interacted with hearing impairment such that hyperglycemia in the contex
262 nt was independent of known risk factors for hearing impairment, such as noise exposure, ototoxic med
263 he acoustic startle response consistent with hearing impairment, suggesting a novel role for Rsph9 in
264 lying neurodegenerative disorder or isolated hearing impairment tended to hear more persistent music,
265 ently believed to be permanent, resulting in hearing impairment that affects more than 10% of the pop
266 air cell survival and therefore minimize the hearing impairment that normally occurs with aging and/o
267 with universal newborn screening and 57 had hearing impairment that was confirmed by nine months of
268 Tecta domains causing mid- or high-frequency hearing impairments that are either stable or progressiv
269 e been linked to the most frequent monogenic hearing impairment, the recessive isolated deafness DFNB
270 th a relative frequency greater than 4% were hearing impairment (three [3%] of 93 patients in the SRS
275 ent, mobility impairment, vision impairment, hearing impairment, urinary incontinence, and impairment
276 urance, participants with moderate or severe hearing impairment walked a mean distance of -2.81 m (95
280 n fully adjusted logistic regression models, hearing impairment was associated with higher odds of lo
290 hildren and 0.0% of controls (P < .001), and hearing impairment was observed in 2.1% of extremely pre
291 for low- or mid-frequency and high-frequency hearing impairment were 1.82 [CI, 1.27 to 2.60] and 2.16
292 r increase in birth year, the odds of having hearing impairment were 13% lower in men (odds ratio = 0
294 of the baseline scores paralleled degree of hearing impairment when impairment was defined using a b
295 t at 4 weeks most showed variable degrees of hearing impairment, which became severe or profound in a
296 Four subjects from three families reported hearing impairment, which has not previously been report
297 Atp6v1b1vtx/vtx mutant mice exhibit profound hearing impairment, which is associated with enlarged en
298 fferent types of gene products can result in hearing impairment, which, given the complexity of the a
299 This stop-gained mutation segregated with hearing impairment within the family and was not identif